Insufficient scRNA-seq data for expression of NPFFR2 at single-cell level.
Insufficient scRNA-seq data for expression of NPFFR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ureter | 0% | 0 | 0 / 0 | 100% | 6.38 | 1 / 1 |
thymus | 66% | 8.70 | 433 / 653 | 30% | 1.42 | 181 / 605 |
breast | 73% | 25.24 | 333 / 459 | 18% | 0.87 | 205 / 1118 |
bladder | 67% | 39.14 | 14 / 21 | 12% | 1.17 | 60 / 504 |
esophagus | 64% | 13.81 | 931 / 1445 | 10% | 1.26 | 19 / 183 |
brain | 54% | 14.87 | 1434 / 2642 | 1% | 0.02 | 10 / 705 |
spleen | 47% | 3.87 | 113 / 241 | 0% | 0 | 0 / 0 |
prostate | 44% | 11.78 | 108 / 245 | 2% | 0.04 | 8 / 502 |
adrenal gland | 9% | 0.81 | 23 / 258 | 34% | 5.51 | 79 / 230 |
kidney | 36% | 4.16 | 32 / 89 | 7% | 0.24 | 60 / 901 |
skin | 32% | 3.29 | 577 / 1809 | 9% | 0.84 | 43 / 472 |
stomach | 35% | 2.84 | 125 / 359 | 5% | 0.29 | 15 / 286 |
intestine | 36% | 3.31 | 349 / 966 | 2% | 0.07 | 9 / 527 |
blood vessel | 38% | 3.25 | 501 / 1335 | 0% | 0 | 0 / 0 |
adipose | 37% | 6.85 | 445 / 1204 | 0% | 0 | 0 / 0 |
lung | 14% | 1.50 | 82 / 578 | 14% | 1.18 | 166 / 1155 |
ovary | 19% | 1.75 | 35 / 180 | 8% | 1.10 | 35 / 430 |
heart | 22% | 1.82 | 186 / 861 | 0% | 0 | 0 / 0 |
liver | 1% | 0.05 | 3 / 226 | 20% | 1.70 | 81 / 406 |
muscle | 17% | 2.01 | 140 / 803 | 0% | 0 | 0 / 0 |
uterus | 8% | 0.58 | 14 / 170 | 8% | 0.62 | 39 / 459 |
pancreas | 7% | 0.38 | 24 / 328 | 6% | 0.33 | 11 / 178 |
peripheral blood | 4% | 0.47 | 41 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.20 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0043408 | Biological process | regulation of MAPK cascade |
GO_0009582 | Biological process | detection of abiotic stimulus |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0042277 | Molecular function | peptide binding |
GO_0031628 | Molecular function | opioid receptor binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0008188 | Molecular function | neuropeptide receptor activity |
Gene name | NPFFR2 |
Protein name | Neuropeptide FF receptor 2 Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor) Neuropeptide FF receptor 2 (cDNA FLJ75415, highly similar to Homo sapiens G protein-coupled receptor 74 (GPR74), transcript variant 2, mRNA) |
Synonyms | NPGPR hCG_15026 GPR74 NPFF2 |
Description | FUNCTION: Receptor for NPAF (A-18-F-amide) and NPFF (F-8-F-amide) neuropeptides, also known as morphine-modulating peptides. Can also be activated by a variety of naturally occurring or synthetic FMRF-amide like ligands. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. FUNCTION: Receptor for NPAF (A-18-F-amide) and NPFF (F-8-F-amide) neuropeptides, also known as morphine-modulating peptides. Can also be activated by a variety of naturally occurring or synthetic FMRF-amide like ligands. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. . FUNCTION: Receptor for NPAF (A-18-F-amide) and NPFF (F-8-F-amide) neuropeptides, also known as morphine-modulating peptides. Can also be activated by a variety of naturally occurring or synthetic FMRF-amide like ligands. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. . |
Accessions | ENST00000344413.6 A0PJM9 Q9Y5X5 ENST00000308744.12 [Q9Y5X5-2] A0A804CC06 ENST00000395999.5 [Q9Y5X5-3] ENST00000358749.3 [Q9Y5X5-2] |